Bunker Mathew B reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology Inc. senior vice president of operations Mathew B. Bunker received a grant of 203 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Microchip common stock. The RSUs will vest in full on May 15, 2027, provided he remains a service provider through that date, and vested shares will be delivered upon vesting.
After this filing, Bunker is shown holding 25,158 shares of Microchip common stock directly, along with the 203 newly granted RSUs.
Bjornholt James Eric reported acquisition or exercise transactions in this Form 4 filing.
Microchip Technology Senior VP and CFO James Eric Bjornholt reported a compensation-related equity grant and his indirect holdings. He received 279 restricted stock units, each representing a contingent right to one share of Microchip common stock. These units will vest in full on May 15, 2027, provided he continues as a service provider through that date, and the vested shares will be delivered upon vesting.
The filing also shows 28,573 shares of common stock held indirectly through a trust. No open-market purchases or sales were reported, making this a routine update to disclose equity awards and existing indirect ownership.
Microchip Technology reported strong results for the quarter ended March 31, 2026, with net sales of $1.311 billion, up 35.1% year over year and above its prior guidance midpoint of $1.260 billion. GAAP diluted EPS was $0.21, while non-GAAP diluted EPS reached $0.57, topping the earlier non-GAAP guidance range of $0.48 to $0.52.
Non-GAAP operating income for the quarter was $400.9 million, or 30.6% of net sales, compared to 14.0% a year earlier, showing substantial margin expansion. For fiscal 2026, net sales were $4.713 billion, up 7.1%, with non-GAAP net income of $933.9 million and non-GAAP EPS of $1.64, both rising more than 25% versus the prior year.
Management guided first-quarter fiscal 2027 net sales to $1.442–$1.469 billion, implying 35.3% year-over-year and 11% sequential growth at the midpoint, and expects non-GAAP EPS of $0.67–$0.71. The company highlighted improving demand, inventory reductions, growing data center and AI design activity, and strong free cash flow of $242.8 million in the quarter. It also declared a quarterly common dividend of $0.455 per share and a preferred dividend of $18.750 per Series A share.
Microchip Technology (MCHP) director, president, CEO and chair Steve Sanghi reported two indirect open‑market sales of common stock by entities associated with him under a Rule 10b5‑1 trading plan. On April 30, 2026, 33,502 shares were sold at an average price of $92.3729 per share. On May 1, 2026, 76,469 shares were sold at an average price of $93.5843 per share, for total reported sales of 109,971 shares. After these transactions, 9,385,834 shares of Microchip Technology common stock are reported as indirectly held, including shares held by The Sanghi Trust and The Sanghi Family Limited Partnership.
Microchip Technology reported insider sale activity by Steve Sanghi via Form 144. The filing lists three sales in the past three months: 94,869 shares on 02/12/2026 for $7,823,191.83, 416,581 shares on 04/23/2026 for $36,880,749.10, and 33,502 shares on 04/30/2026 for $3,094,676.90. The filing also shows prior option exercises (37,920; 25,000) and an RSU vesting (13,549).
Microchip Technology (MCHP) notice of proposed sale: the filing lists proposed sales of Common Stock under Rule 144 and discloses prior sales during the past three months by Steve Sanghi. The excerpt shows prior disposals of 94,869 shares on 02/12/2026 and 416,581 shares on 04/23/2026 with reported aggregate values of $7,823,191.83 and $36,880,749.10, respectively.
The filing also references a block of 33,502 shares tied to an option exercise (11/14/2012) and lists Fidelity Brokerage Services LLC as a broker address. The notice is a routine regulatory disclosure of proposed resale activity under Rule 144.
Vanguard Capital Management files a Schedule 13G reporting beneficial ownership of 7.50% of Microchip Technology Inc common stock. The filing states Vanguard Capital Management beneficially owns 40,620,884 shares and reports sole dispositive power over 40,620,884 shares and sole voting power for 5,495,811 shares as of 03/31/2026. The filing notes ownership includes securities held for Vanguard funds and managed accounts under the reporting business unit. The filing is signed by Vanguard's Head of Global Fund Administration on 04/30/2026.
Vanguard Portfolio Management reported beneficial ownership of 32,469,341 shares of Microchip Technology Inc. common stock, representing 6% of the class as of 03/31/2026. The filing shows sole voting power for 63,962 shares and sole dispositive power for 32,469,341 shares. The report is signed by Ashley Grim on 04/29/2026.
Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 416,581 shares of Common Stock at $88.5329 per share under a pre-arranged Rule 10b5-1 trading plan. After this indirect sale through a trust and a family limited partnership, he continues to hold 9,495,805 shares indirectly.
Microchip Technology reports proposed insider sales via Form 144. The filing lists planned dispositions of common stock tied to vested RSUs and option exercises and shows two recent sale filings: 94,869 shares on 02/12/2026 and 98,814 shares on 01/28/2026. The filing names Fidelity Brokerage Services LLC as broker.